Invention Grant
- Patent Title: Substituted fused imidazoles and pyrazoles and use thereof
- Patent Title (中): 取代的稠合咪唑和吡唑及其用途
-
Application No.: US13736692Application Date: 2013-01-08
-
Publication No.: US09023849B2Publication Date: 2015-05-05
- Inventor: Markus Follmann , Johannes-Peter Stasch , Gorden Redlich , Nils Griebenow , Dieter Lang , Frank Wunder , Holger Paulsen , Walter Hübsch , Alexandros Vakalopoulos , Adrian Tersteegen
- Applicant: Bayer Intellectual Property GmbH
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: DE102012200352 20120111
- Main IPC: A61K31/5365
- IPC: A61K31/5365 ; C07D253/00 ; C07D487/04 ; C07D519/00 ; A61K31/519 ; A61K31/53 ; A61K45/06
Abstract:
The present application relates to novel substituted fused imidazoles and pyrazoles, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases and to the use thereof producing medicaments for the treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of cardiovascular disorders.
Public/Granted literature
- US20130210824A1 Substituted fused imidazoles and pyrazoles and use thereof Public/Granted day:2013-08-15
Information query
